Developmental and epileptic encephalopathy, 13
MONDO:0013801Any early infantile epileptic encephalopathy in which the cause of the disease is a mutation in the SCN8A gene.
Also known as: DEE13, EIEE13, SCN8A early infantile epileptic encephalopathy, developmental and epileptic encephalopathy 13, early infantile epileptic encephalopathy caused by mutation in SCN8A, early infantile epileptic encephalopathy-13, epileptic encephalopathy, early infantile, 13, epileptic encephalopathy, early infantile, type 13
65 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Promising seizure drug study halted early
Disease control TerminatedThis study looked at the long-term safety of the drug NBI-921352 for people with a rare genetic seizure disorder called SCN8A-DEE. It was an extension of an earlier study, and participants took the drug alongside their usual seizure medications. The study was stopped early and on…
Phase: PHASE2 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug shows promise for Tough-to-Treat seizures in kids
Disease control TerminatedThis study looked at the long-term safety of soticlestat, an experimental drug, in children and adults with severe forms of epilepsy like Dravet syndrome and Lennox-Gastaut syndrome. Participants took soticlestat twice a day along with their usual seizure medicines. The study was…
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Promising epilepsy drug trial halted early – what we know
Disease control TerminatedThis study tested an experimental drug called NBI-921352 in people aged 2 to 21 with a rare, severe form of epilepsy caused by a change in the SCN8A gene. The goal was to see if adding this drug to their current seizure medicines could reduce how often they had seizures. The tria…
Phase: PHASE2 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC